Beat Childhood Cancer at Penn State College of Medicine Launches AI-Powered Patient Engagement Platform with WeTrials to Expand Access to Pediatric Cancer Clinical Trials

2026-08-28T09:26:18-04:00August 28th, 2026|

Collaboration aims to advance patient-centered clinical research, making it more accessible, understandable and actionable for families HERSHEY, Pa. — Tuesday, July 7, 2026 — Beat Childhood Cancer (BCC) at Penn State College of Medicine, an international pediatric cancer research consortium comprising more than 50 hospitals and research institutions across North America, South America and Europe, [...]

Read More

Penn State advances pediatric cancer research through new targeted therapy collaboration

2026-01-08T09:28:49-05:00January 8th, 2026|

Penn State College of Medicine is advancing its commitment to cutting-edge cancer research and early-phase clinical trials through a new collaboration aimed at accelerating a promising targeted therapy for pediatric brain cancer. Through its leadership of the Beat Childhood Cancer Research Consortium and Four Diamonds in partnership with Targepeutics, the College of Medicine will help advance [...]

Read More

Penn State’s Beat Childhood Cancer Research Consortium welcomes SJD Pediatric Cancer Center Barcelona, strengthening global leadership in pediatric cancer research

2025-11-24T12:50:43-05:00November 24th, 2025|

The Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Déu has become the first center outside North America to join the Beat Childhood Cancer (BCC) Research Consortium, an international pediatric cancer research organization that, until now, included only institutions from the United States and Canada. See full article.

Read More

Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors

2024-09-30T13:23:27-04:00September 30th, 2024|

In a step toward fighting solid tumors in children and young adults, Penn State College of Medicine, the Beat Childhood Cancer Research Consortium and Four Diamonds, along with Senhwa Biosciences, Inc. are launching a pioneering clinical trial. The study aims to evaluate the investigational drug, silmitasertib, in combination with FDA-approved drugs for solid tumors. This innovative trial seeks to establish a [...]

Read More

Q&A: Finding novel therapies for childhood cancer

2024-08-14T14:28:21-04:00August 14th, 2024|

Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new diagnoses every year. The survival rate is 30% and for patients who relapse following conventional standard of care treatments, the survival rate [...]

Read More

FDA approves pediatric neuroblastoma drug based on Penn State professor’s work

2023-12-15T08:07:56-05:00December 15th, 2023|

Giselle Saulnier Sholler, professor of pediatrics and of pharmacology, reflects on 20 years working to change cancer outcomes for children HERSHEY, Pa. — In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler’s first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the [...]

Read More

US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer

2023-12-15T08:08:24-05:00December 15th, 2023|

LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk neuroblastoma. IWILFIN is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who have demonstrated at least a partial [...]

Read More

Penn State Health recruits leading researcher to fight pediatric cancer

2023-08-08T10:20:09-04:00August 8th, 2023|

Cris Collingwood//August 2, 2023 An internationally known physician-scientist and her research consortium have joined Penn State Health to continue efforts to eradicate pediatric cancer.  Penn State Health and Penn State College of Medicine said Dr. Giselle Saulnier Sholler and her research team will be on board Sept. 1 to provide greater access to pediatric care and research, including [...]

Read More

The Power of Will

2023-08-08T10:22:34-04:00December 8th, 2016|

Will Lacey was just a baby when doctors diagnosed a rare form of cancer and told his family there was only one end. Nobody then could imagine the journey ahead, from hospital rooms to board rooms, research labs to government offices, a furious race between hope and death. WRITTEN BY BILLY BAKERILLUSTRATED BY TONIA COWAN Boston [...]

Read More

© Copyright 2026 Beat Childhood Cancer Research Consortium

Loading...
Go to Top